This inventor holds 1 USPTO granted patent. Top assignees: Merck Sharp & Dohme LLC, Msd R&D (China) Co., Ltd., Walter and Eliza Hall Institute of Medical Research. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: The Innovative Contributions of Brad Sleebs
Introduction
Brad Sleebs is an accomplished inventor based in Victoria, Australia. He has made significant contributions to the field of medicine, particularly in the development of antimalarial agents. His work focuses on providing effective methods for treating malaria, a disease that continues to affect millions worldwide.
Latest Patents
Brad Sleebs holds a patent for antimalarial agents, which includes methods of treating malaria through the administration of specific compounds. The patent details the use of compounds of Formula (I) or their pharmaceutically acceptable salts to treat subjects in need. Additionally, it outlines the potential uses of these compounds for treating infections and malaria, as well as methods that may involve the administration of additional anti-malarial compounds.
Career Highlights
Throughout his career, Brad has worked with notable companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme LLC and MSD R&D (China) Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative treatments for malaria.
Collaborations
Brad has collaborated with several professionals in his field, including Manuel De Lera Ruiz and Paola Favuzza. These collaborations have likely enhanced his research and development efforts, leading to advancements in antimalarial treatments.
Conclusion
Brad Sleebs is a dedicated inventor whose work in antimalarial agents showcases his commitment to improving global health. His contributions are vital in the ongoing fight against malaria, and his innovative approaches continue to inspire advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile